LIXT   $2.74  -6.16% Market Closed

Lixte Biotechnology Holdings, Inc.
Total Cash 2.60M
totalCashPerShare 1.154
EBITDA
Total Debt 0.00
quickRatio 6.158
currentRatio 6.329
Total Revenue
debtToEquity
Revenue/Share
ROA -0.87331
ROE -1.63334
grossProfits
freeCashflow -1.95M
operatingCashflow -3.45M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 5.16M
forwardPE
floatShares 1.98M
sharesOutstanding 2.25M
sharesShort 18.32K
sharesShortPriorMonth 34.59K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.20%
heldPercentInstitutions 0.09%
Short Ratio help_outline 2.38%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue -0.557
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -4.03M
trailingEps -1.72%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 6
lastUpdated Nov. 7, 2024, 3:29 a.m.